Catalog Number
SALK10002
Product Name
LDN193189
CAS Number
1062368-24-4
IUPAC Name
4-[6-(4-piperazin-1-ylphenyl)pyrazolo[1,5-a]pyrimidin-3-yl]quinoline
Synonyms
LDN 193189, LDN-193189, DM-3189
Molecular Formula
C25H22N6
Molecular Weight
406.48
Appearance
Solid Powder
Purity
99.86%
Density
1.33 g/cm3
Solubility
DMSO: Insoluble Water: Insoluble ( < 1 mg/ml refers to the product slightly soluble or insoluble )
Storage
Powder: -20°C for 3 years In solvent: -80°C for 6 months
Description
LDN-193189 is a selective BMP signaling pathway inhibitor that inhibits the transcriptional activity of ALK2 and ALK3, the BMP TYPE I receptors, with IC50 of 5 nM and 30 nM, respectively. The effect of LDN-193189 on BMP is 200 times higher than that of TGF-β.
SMILES
C1CN(CCN1)C2=CC=C(C=C2)C3=CN4C(=C(C=N4)C5=CC=NC6=CC=CC=C56)N=C3
InChI
InChI=1S/C25H22N6/c1-2-4-24-22(3-1)21(9-10-27-24)23-16-29-31-17-19(15-28-25(23)31)18-5-7-20(8-6-18)30-13-11-26-12-14-30/h1-10,15-17,26H,11-14H2
InChI Key
CDOVNWNANFFLFJ-UHFFFAOYSA-N
Target
ALK2, ALK3
Inquiry

new products